Skip to Main Content

WASHINGTON — Democratic presidential candidates are making bigger promises than ever before on reforming the pharmaceutical industry.

But the candidates have not formulated the policies on their own. Instead, to workshop the bold and occasionally far-fetched ideas, Democrats have turned to a familiar cast of outside advisers, according to drug pricing advocates, Capitol Hill aides, and the campaigns themselves.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!